Table of Contents Author Guidelines Submit a Manuscript
International Journal of Dentistry
Volume 2014 (2014), Article ID 935657, 10 pages
http://dx.doi.org/10.1155/2014/935657
Clinical Study

New Dimensional Staging of Bisphosphonate-Related Osteonecrosis of the Jaw Allowing a Guided Surgical Treatment Protocol: Long-Term Follow-Up of 266 Lesions in Neoplastic and Osteoporotic Patients from the University of Bari

1Department of Interdisciplinary Medicine, Odontostomatology Unit, Faculty of Medicine, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124 Bari, Italy
2Plastic, Reconstructive and Aesthetic Surgery Unit, Campus Bio-Medico University, Via Alvaro del Portillo 21, 00128 Rome, Italy
3Department of Emergency and Organ Transplantation, Pathological Anatomy Unit, Faculty of Medicine, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124 Bari, Italy

Received 7 March 2014; Accepted 22 April 2014; Published 5 June 2014

Academic Editor: Giuliano Ascani

Copyright © 2014 Simonetta Franco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Boonyapakorn, I. Schirmer, P. A. Reichart, I. Sturm, and G. Massenkeil, “Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies,” Oral Oncology, vol. 44, no. 9, pp. 857–869, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Green and P. Clézardin, “The molecular basis of bisphosphonate activity: a preclinical perspective,” Seminars in Oncology, vol. 37, supplement 1, pp. S3–S11, 2010. View at Google Scholar
  3. H. Fleisch, “Bisphosphonates: mechanisms of action,” Endocrine Reviews, vol. 19, no. 1, pp. 80–100, 1998. View at Google Scholar · View at Scopus
  4. M. J. Rogers, S. Gordon, H. L. Benford et al., “Cellular and molecular mechanisms of action of bisphosphonates,” Cancer, vol. 88, supplement 2, pp. 2961–2978, 2000. View at Google Scholar · View at Scopus
  5. M. J. Rogers, “New insights into the molecular mechanisms of action of bisphosphonates,” Current Pharmaceutical Design, vol. 9, no. 32, pp. 2643–2658, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. R. E. Marx, “Pamidronate (aredia) and zoledronate (zometa) induced avascular necrosis of the jaws: a growing epidemic,” Journal of Oral and Maxillofacial Surgery, vol. 61, no. 9, pp. 115–117, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Fleish, “Bisphosphonates: mechanism of action,” Endocrine Reviews, vol. 19, pp. 80–100, 1998. View at Google Scholar
  8. S. L. Ruggiero, B. Mehrotra, T. J. Rosenberg, and S. L. Engroff, “Osteonecrosis of the Jaws associated with the use of bisphosphonates: a review of 63 cases,” Journal of Oral and Maxillofacial Surgery, vol. 62, no. 5, pp. 527–534, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Colella, G. Campisi, and V. Fusco, “American Association of Oral and Maxillofacial Surgeons Position Paper: bisphosphonate-related osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 12, pp. 2698–2699, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. V. Bagan, Y. Jimenez, J. Murillo et al., “Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases,” Oral Oncology, vol. 42, no. 3, pp. 327–329, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. C. H. Lin, C. S. Liu, and S. W. Lai, “Long-term use oral bisphosphonate-related osteonecrosis of the jaw without dental extraction in elderly: a case report,” Journal of Clinical Gerontology and Geriatrics, vol. 2, no. 1, pp. 30–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. V. Lobato, A. C. Maurício, J. M. Rodrigues et al., “Jaw avascular osteonecrosis after treatment of multiple myeloma with zoledronate,” Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 61, no. 1, pp. 99–106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Tubiana-Hulin, M. Spielmann, C. Roux et al., “Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis,” Critical Reviews in Oncology/Hematology, vol. 71, no. 1, pp. 12–21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. S. Bauer, N. Beck, J. Kiefer, P. Stockmann, M. Wichmann, and S. Eitner, “Awareness and education of patients receiving bisphosphonates,” Journal of Cranio-Maxillofacial Surgery, vol. 40, no. 3, pp. 277–282, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. N. M. H. McLeod, P. A. Brennan, and S. L. Ruggiero, “Bisphosphonate osteonecrosis of the jaw: a historical and contemporary review,” Surgeon, vol. 10, no. 1, pp. 36–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws, “Advisory task force on bisphosphonate-related osteonecrosis of the Jaws,” Journal of Oral and Maxillofacial Surgery, vol. 65, pp. 369–376, 2007. View at Google Scholar
  17. G. Favia, G. P. Pilolli, and E. Maiorano, “Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients,” Journal of Rheumatology, vol. 36, no. 12, pp. 2780–2787, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. I. J. Diel, I. Fogelman, B. Al-Nawas et al., “Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: is there a diverse relationship of amino- and non-aminobisphosphonates?” Critical Reviews in Oncology/Hematology, vol. 64, no. 3, pp. 198–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Otto, M. H. Abu-Id, S. Fedele et al., “Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence—a multi-centre study,” Journal of Cranio-Maxillofacial Surgery, vol. 39, no. 4, pp. 272–277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. T. S. Lazarovici, R. Yahalom, S. Taicher, S. Elad, I. Hardan, and N. Yarom, “Bisphosphonate-related osteonecrosis of the Jaws: a single-center study of 101 patients,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 4, pp. 850–855, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Kos, J. F. Kuebler, K. Luczak, and W. Engelke, “Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk,” Journal of Cranio-Maxillofacial Surgery, vol. 38, no. 4, pp. 255–259, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Jadu, L. Lee, M. Pharoah, D. Reece, and L. Wang, “A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients,” Annals of Oncology, vol. 18, no. 12, pp. 2015–2019, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Ortega, F. Montemurro, R. Faggiuolo et al., “Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis,” Acta Oncologica, vol. 46, no. 5, pp. 664–668, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. B. Aragon-Ching, Y.-M. Ning, C. C. Chen et al., “Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents,” Cancer Investigation, vol. 27, no. 2, pp. 221–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Christodoulou, A. Pervena, G. Klouvas et al., “Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone,” Oncology, vol. 76, no. 3, pp. 209–211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Zervas, E. Verrou, Z. Teleioudis et al., “Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients,” British Journal of Haematology, vol. 134, no. 6, pp. 620–623, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. L. Ruggiero, J. Fantasia, and E. Carlson, “Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 102, no. 4, pp. 433–441, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. R. E. Marx, Oral and Intravenous Bisphosphonate-Induced Osteonecrosis of the Jaw, Quintessence, Chicago, Ill, USA, 2007.
  29. A. Bedogni, V. Fusco, A. Agrillo, and G. Campisi, “Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ),” Oral Diseases, vol. 18, pp. 621–623, 2012. View at Google Scholar
  30. P. Vescovi and S. Nammour, “Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review,” Minerva Stomatologica, vol. 59, no. 4, pp. 181–213, 2010. View at Google Scholar · View at Scopus
  31. R. E. Marx, Y. Sawatari, M. Fortin, and V. Broumand, “Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment,” Journal of Oral and Maxillofacial Surgery, vol. 63, no. 11, pp. 1567–1575, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Vescovi, M. Manfredi, E. Merigo, and M. Meleti, “Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the Jaws,” Journal of Oral and Maxillofacial Surgery, vol. 66, no. 4, pp. 831–832, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. Migliorati, M. A. Siegel, and L. S. Elting, “Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment,” The Lancet Oncology, vol. 7, no. 6, pp. 508–514, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. I. R. Reid, “Osteonecrosis of the jaw—who gets it, and why?” Bone, vol. 44, no. 1, pp. 4–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Blus, S. Szmukler-Moncler, G. Giannelli, G. Denotti, and G. Orrù, “Use of ultrasonic bone surgery (Piezosurgery) to surgically treat bisphosphonate-related osteonecrosis of the Jaws (BRONJ). A case series report with at least 1 year of follow-up,” Open Dentistry Journal, vol. 23, no. 7, pp. 94–101, 2013. View at Google Scholar
  36. M. A. Mariggiò, A. Cassano, A. Vinella et al., “Enhancement of fibroblast proliferation, collagen biosynthesis and production of growth factors as a result of combining sodium hyaluronate and aminoacids,” International Journal of Immunopathology and Pharmacology, vol. 22, no. 2, pp. 485–492, 2009. View at Google Scholar · View at Scopus
  37. G. Favia, M. A. Mariggiò, E. Maiorano, A. Cassano, S. Capodiferro, and D. Ribatti, “Accelerated wound healing of oral soft tissues and angiogenic effect induced by a pool of aminoacids combined to sodium hyaluronate (AMINOGAM),” Journal of Biological Regulators and Homeostatic Agents, vol. 22, no. 2, pp. 109–116, 2008. View at Google Scholar · View at Scopus
  38. T. Sasaki and C. Watanabe, “Stimulation of osteoinduction in bone wound healing by high-molecular hyaluronic acid,” Bone, vol. 16, no. 1, pp. 9–15, 1995. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Kawano, W. Ariyoshi, K. Iwanaga et al., “Mechanism involved in enhancement of osteoblast differentiation by hyaluronic acid,” Biochemical and Biophysical Research Communications, vol. 405, no. 4, pp. 575–580, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Sengupta, S.-H. Park, A. Patel, J. Carn, K. Lee, and D. L. Kaplan, “Hypoxia and amino acid supplementation synergistically promote the osteogenesis of human mesenchymal stem cells on silk protein scaffolds,” Tissue Engineering A, vol. 16, no. 12, pp. 3623–3634, 2010. View at Publisher · View at Google Scholar · View at Scopus